Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2010 by Oslo University Hospital.
Recruitment status was:  Recruiting
Helse Sor-Ost
Information provided by:
Oslo University Hospital Identifier:
First received: April 19, 2010
Last updated: May 6, 2010
Last verified: January 2010
In this study the investigators aim at comparing the effect on quality of life and the cost-effectiveness of a structuralised sick-leave program compared to usual care sick leave management in patients after an acute non ST myocardial infarction(NSTEMI).The investigators hypothesize that a structuralised sick-leave program after an acute NSTEMI is cost-effective without a negative effect on quality of life compared to usual care management in this patient group.

Condition Intervention
Myocardial Infarction
Other: Usual care sick-leave management
Other: Structuralised sick-leave program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction

Resource links provided by NLM:

Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Cost effectiveness [ Time Frame: one year ]
    In order to evaluate resource use (costs) all patients will be asked to fill in a questionnaire at baseline and after 6 and 12 months. Total costs and mean costs will be calculated in the two different follow-up modalities.

Secondary Outcome Measures:
  • Quality of Life measures are estimated at baseline and after 6 and 12 months using the standard Medical Outcomes Study Short form( SF-36)questionnaire and the disease-specific Utility-Based Quality of life-Heart questionnaire(UBQ-H). [ Time Frame: one year ]

Estimated Enrollment: 120
Study Start Date: January 2010
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Group 1: Usual care sick-leave management Other: Usual care sick-leave management
Patients randomized to usual care. Follow up after discharge by general practitioner (GP) according to local practice.
Group 2: Structuralised sick-leave program Other: Structuralised sick-leave program
Patients randomized to the structuralized program will get full time sick-leave for 2 weeks after discharge.Cardiologist will be responsible for individual adaption of each patient`s sick-leave and follow-up.


Ages Eligible for Study:   up to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with acute NSTEMI who are revascularized.
  • 65 years old or less
  • Self caring
  • Adequately literate in Norwegian
  • Have a regular work in at least 50% position.

Exclusion Criteria:

  • Patients not willing to participate
  • Professional drivers
  • Patients with alcohol or drug abuse
  • Severe complications after the myocardial infarction such as malignant arrythmias, heart failure and major bleedings.
  • Patients with recent CABG ( coronary artery bypass graft operation) within the last 6 months.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01108653

Contact: Stefan Agewall, Professor, MD.PhD +4722894655
Contact: Liv Mundal, MD +4793268387

Oslo University Hospital Recruiting
Oslo, Trondheimsveien 235, Norway, 0514
Principal Investigator: Stefan Agewall, Professor         
Sponsors and Collaborators
Oslo University Hospital
Helse Sor-Ost
Principal Investigator: Stefan Agewall, Professor Oslo University Hospital. Department of Cardiology. Trondheimsveien 235, 0514 Oslo, Norway
  More Information

Responsible Party: Oslo University Hospital. Trondheimsveien 235,0514 Oslo, Norway.(Professor Stefan Agewall), Oslo University Hospital Identifier: NCT01108653     History of Changes
Other Study ID Numbers: REK sør-øst B:2009/719b
Study First Received: April 19, 2010
Last Updated: May 6, 2010

Keywords provided by Oslo University Hospital:
Cardiovascular diseases
Heart diseases
Myocardial infarction
Health Economy
Randomized controlled trials
Non ST Elevation Myocardial Infarction (NSTEMI)
Cost analysis
Quality of Life

Additional relevant MeSH terms:
Myocardial Infarction
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on May 22, 2017